{"schema_version":"secwatch.filing_event.v1","accession":"0000939930-22-000014","form_type":"8-K","ticker":"PYYX","cik":"0000939930","company_name":"PYXUS INTERNATIONAL, INC.","filed_at":"2022-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.474964+00:00","generated_at":"2026-06-27T09:26:46.179713+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pyxus Q3 revenue up 13% to $428.9M; exits cannabis ops; new $100M ABL","bullets":["Sales $428.9M (+13.0% YoY); gross profit $65.2M (+4.3%); SG&A down 25.5% to $34.2M.","Cash $146.1M, up $22.9M; $15.4M prepayment on Delayed Draw Term Loan in Dec 2021.","Completed sale of FIGR Norfolk assets in Jan 2022, exiting cash-flow-negative cannabinoid ops.","New $100M ABL credit facility with PNC Bank replaces $75M facility; lower rate, extended maturity.","FY2022 guidance: revenue $1.55B-$1.7B; adjusted EBITDA $125M-$145M; expects COVID shipping delays."],"urls":{"canonical":"https://secwatch.observer/filing/0000939930-22-000014","json":"https://secwatch.observer/filing/0000939930-22-000014.json","markdown":"https://secwatch.observer/filing/0000939930-22-000014.md","text":"https://secwatch.observer/filing/0000939930-22-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/939930/000093993022000014/0000939930-22-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/939930/000093993022000014/pyx-20220210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T09:26:46.179713+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}